Patents by Inventor Zhiqing Yang

Zhiqing Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952283
    Abstract: A silicon-and germanium-based molecular sieve has a framework chemical composition as represented by the formula “SiO2.1/nGeO2”. The silicon/germanium molar ratio is 0.1n30. The molecular sieve has a unique X-ray diffraction pattern. It can be used in adsorptive separation, ion exchange, and catalytic conversion of organic compounds.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: April 9, 2024
    Assignees: CHINA PETROLEUM & CHEMICAL CORPORATION, SHANGHAI RESEARCH INSTITUTE OF PETROCHEMICAL TECHNOLOGY SINOPEC
    Inventors: Weimin Yang, Wenhua Fu, Zhiqing Yuan, Zhendong Wang, Jiawei Teng, Weichuan Tao, Shengli Zhao
  • Publication number: 20240082977
    Abstract: A fully-automatic aluminum thermal-spraying corrosion prevention production line based on robots and visual recognition is provided. The production line comprises an automatic feeding system comprising feeding carrying and conveying mechanisms; a laser derusting system comprising a derusting robot, a laser cleaning nozzle and derusting conveying mechanisms; an aluminum thermal-spraying system comprising an aluminum spraying robot and an aluminum thermal-spraying gun; an automatic rolling system comprising a rolling pedestal, a first rolling wheel, a second rolling wheel and a rolling drive mechanism; a laser cutting system; and a discharging and stacking system.
    Type: Application
    Filed: April 19, 2022
    Publication date: March 14, 2024
    Applicant: GUIZHOU POWER GRID CO., LTD
    Inventors: Bo LI, Zhuoyi LIU, Jun LIU, Jingxin TU, Zhiqing ZHANG, Xi FANG, Shifeng LIU, Xianwu ZENG, Dan YANG, Jinke LU, Wei DU
  • Publication number: 20220220107
    Abstract: Crystal forms A, B, C, D, E, F, G and H of a compound represented by formula I and a preparation method therefor, as well as medical uses for the various crystal forms and advantages thereof in various aspects.
    Type: Application
    Filed: May 21, 2020
    Publication date: July 14, 2022
    Applicant: ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
    Inventors: Jianfeng ZHENG, Liang ZHANG, Min ZHAO, Zhenjuan SHI, Xufei LI, Zhiqing YANG
  • Patent number: 11038432
    Abstract: Provided is a power conversion device including a power converter for performing power conversion between primary-side DC voltage and secondary-side DC voltage, and a control device for controlling the power converter in accordance with a command value, wherein the control device generates a primary-side duty for a primary-side bridge circuit, a secondary-side duty for a secondary-side bridge circuit, and a phase shift amount between the primary-side bridge circuit and the secondary-side bridge circuit, on the basis of a solution of an optimization problem for minimizing a peak absolute value of current flowing through the transformer, under a constraint condition that zero voltage switching operation is achieved, at an operation point based on the command value, thus achieving zero voltage switching operation and suppressing increase in conduction loss, without increase in the number of components.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: June 15, 2021
    Assignee: MITSUBISHI ELECTRIC CORPORATION
    Inventors: Takuya Kajiyama, Takaharu Ishibashi, Zhiqing Yang
  • Publication number: 20200274457
    Abstract: Provided is a power conversion device including a power converter for performing power conversion between primary-side DC voltage and secondary-side DC voltage, and a control device for controlling the power converter in accordance with a command value, wherein the control device generates a primary-side duty for a primary-side bridge circuit, a secondary-side duty for a secondary-side bridge circuit, and a phase shift amount between the primary-side bridge circuit and the secondary-side bridge circuit, on the basis of a solution of an optimization problem for minimizing a peak absolute value of current flowing through the transformer, under a constraint condition that zero voltage switching operation is achieved, at an operation point based on the command value, thus achieving zero voltage switching operation and suppressing increase in conduction loss, without increase in the number of components.
    Type: Application
    Filed: April 9, 2018
    Publication date: August 27, 2020
    Applicant: Mitsubishi Electric Corporation
    Inventors: Takuya KAJIYAMA, Takaharu ISHIBASHI, Zhiqing YANG
  • Patent number: 10669302
    Abstract: Provided are a new crystal form of fludarabine phosphate, a preparation method therefor, a pharmaceutical composition containing same, and an application thereof in preparing medicine. Crystal forms I and II of the fludarabine phosphate have excellent properties in terms of solubleness, dissolution rate, chemical stability, and processing adaptability.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: June 2, 2020
    Assignee: ZHEJIANF HISUN PHARMACEUTICAL CO., LTD.
    Inventors: Zhiqing Yang, Liang Zhang, Xiangyang Zhang, Zhenjuan Shi, Di Su, Hongying Luo, Dejin Fu
  • Patent number: 10442835
    Abstract: The present invention relates to technical fields of organic chemistry and pharmaceutical chemistry, specifically to water-soluble rapamycin derivatives modified with glutathione. More specifically, the present invention discloses a compound of formula I and the preparation method thereof, wherein R1 and R2 are as defined in the description. The compound of formula I can be used in inducing immunosuppression and in the treatment of diseases such as transplant rejection and solid tumor, etc.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: October 15, 2019
    Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Haibo Wang, Hongfu Kuang, Wei Zhang, Zhengjiang Cai, Tianmin Zhu, Xiaohe Zheng, Zhongwei Wu, Zhiqing Yang
  • Patent number: 10364244
    Abstract: Provided are crystal forms I, II, III and IV of a pyrroloquinoline quinone sodium salt and a preparation method thereof. Also provided are a pharmaceutical composition, a cosmetic composition, a functional food or a nutritional agent containing the above-mentioned crystal forms. The crystal forms have excellent properties in terms of solubility, crystal stability, hygroscopicity and the like.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: July 30, 2019
    Assignee: ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
    Inventors: Zhiqing Yang, Liang Zhang, Xiangyang Zhang, Zhenjuan Shi, Min Zhao, Hongying Luo
  • Patent number: 10364219
    Abstract: Disclosed is a new method for preparing an azetidinone compound represented by formula (I). The carboxylic ketoester represented by formula (II) serves as the raw material and is subjected to Grignard addition, stereoselective dehydration, ester group reduction, hydroxyl group protection, addition with imine after condensation with a chiral auxiliary, cyclization and deprotection to obtain the compound represented by formula (I). The present invention has advantages of easily available raw material, a few synthetic steps, simple operation, high yield, good stereoselectivity and low cost, and can be used for industrial production.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: July 30, 2019
    Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Hua Bai, Xuyang Zhao, Yuncai Zhang, Xufei Li, Yong Zhang, Dezhou Xu, Li Zhang, Xiaojie Xu, Qifeng Zhu, Xiaoming Wang, Zhiqing Yang, Zehua Zhong, Jian Zhang
  • Publication number: 20190218210
    Abstract: Provided are crystal forms I, II, III and IV of a pyrroloquinoline quinone sodium salt and a preparation method thereof. Also provided are a pharmaceutical composition, a cosmetic composition, a functional food or a nutritional agent containing the above-mentioned crystal forms. The crystal forms have excellent properties in terms of solubility, crystal stability, hygroscopicity and the like.
    Type: Application
    Filed: September 14, 2016
    Publication date: July 18, 2019
    Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Zhiqing YANG, Liang ZHANG, Xiangyang ZHANG, Zhenjuan SHI, Min ZHAO, Hongying LUO
  • Publication number: 20190112327
    Abstract: Provided are a new crystal form of fludarabine phosphate, a preparation method therefor, a pharmaceutical composition containing same, and an application thereof in preparing medicine. Crystal forms I and II of the fludarabine phosphate have excellent properties in terms of solubleness, dissolution rate, chemical stability, and processing adaptability.
    Type: Application
    Filed: August 26, 2016
    Publication date: April 18, 2019
    Inventors: Zhiqing YANG, Liang ZHANG, Xiangyang ZHANG, Zhenjuan SHI, Di SU, Hongying LUO, Dejin FU
  • Publication number: 20190055284
    Abstract: The present invention relates to technical fields of organic chemistry and pharmaceutical chemistry, specifically to water-soluble rapamycin derivatives modified with glutathione. More specifically, the present invention discloses a compound of formula I and the preparation method thereof, wherein R1 and R2 are as defined in the description. The compound of formula I can be used in inducing immunosuppression and in the treatment of diseases such as transplant rejection and solid tumor, etc.
    Type: Application
    Filed: November 9, 2016
    Publication date: February 21, 2019
    Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Haibo Wang, Hongfu Kuang, Wei Zhang, Zhengjiang Cai, Tianmin Zhu, Xiaohe Zheng, Zhongwei Wu, Zhiqing Yang
  • Patent number: 10196360
    Abstract: Provided are crystal forms I, II, and III of bedaquiline fumarate, and preparation methods thereof. The crystal forms have high purity, excellent physicochemical properties, and good stability. The preparation methods can effectively improve the quality of products, and are applicable to preparation and mass production of medicines.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: February 5, 2019
    Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Jinyi Xu, Liang Zhang, Xiangyang Zhang, Xinzeng Wang, Jian Chai, Hongying Luo, Zhiqing Yang
  • Publication number: 20180346506
    Abstract: The present invention relates to a method for preparing Sofosbuvir crystal form-6. The method is simple in operation, stable in process condition, good in reproducibility, high in yield rate and high in purity, viscous gel-type products are not formed during the process, the problem of blocking of a discharge port is solved, and the method is suitable for mass industrial production and has high economic value.
    Type: Application
    Filed: November 11, 2015
    Publication date: December 6, 2018
    Applicant: ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
    Inventors: Yanghui GUO, Shiguo ZHAO, Yue ZHANG, Liang ZHANG, Zhiqing YANG, Jian CHAI
  • Publication number: 20180273526
    Abstract: Provided are crystal forms I, II, III and IV of a pyrroloquinoline quinone sodium salt and a preparation method thereof. Also provided are a pharmaceutical composition, a cosmetic composition, a functional food or a nutritional agent containing the above-mentioned crystal forms. The crystal forms have excellent properties in terms of solubility, crystal stability, hygroscopicity and the like.
    Type: Application
    Filed: September 14, 2016
    Publication date: September 27, 2018
    Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Zhiqing YANG, Liang ZHANG, Xiangyang ZHANG, Zhenjuan SHI, Min ZHAO, Hongying LUO
  • Patent number: 10081599
    Abstract: The present invention relates to a preparation method of 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-formamide capable of enabling 4-chlorine-N-methylpyridine-2-formamide to react with 4-amino-3-fluorophenol in the presence of an inorganic base. The present invention employs the inorganic base to replace potassium t-butoxide in the prior art, thus effectively solving the problem of a potential safety hazard of the potassium t-butoxide in industrial production. In addition, after the reaction is completed, the present invention employs a crystallization method for separation to obtain a reaction product; thus compared with the methods of extraction, concentration and column isolation and purification employed in the prior art, the present invention has a simpler operation and a lower cost, results in less environment pollution and a higher yield, and is very suitable for industrial production.
    Type: Grant
    Filed: November 9, 2015
    Date of Patent: September 25, 2018
    Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Guan Wang, Xufeng Yu, Guo Wei, Jian Chai, Zhiqing Yang
  • Publication number: 20180265473
    Abstract: Provided are crystal forms I, II, and III of bedaquiline fumarate, and preparation methods thereof. The crystal forms have high purity, excellent physicochemical properties, and good stability. The preparation methods can effectively improve the quality of products, and are applicable to preparation and mass production of medicines.
    Type: Application
    Filed: October 20, 2015
    Publication date: September 20, 2018
    Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Jinyi Xu, Liang Zhang, Xiangyang Zhang, Xinzeng Wang, Jian Chai, Hongying Luo, Zhiqing Yang
  • Publication number: 20180244711
    Abstract: Provided are a new crystal form of fludarabine phosphate, a preparation method therefor, a pharmaceutical composition containing same, and an application thereof in preparing medicine. Crystal forms I and II of the fludarabine phosphate have excellent properties in terms of solubleness, dissolution rate, chemical stability, and processing adaptability.
    Type: Application
    Filed: August 26, 2016
    Publication date: August 30, 2018
    Inventors: Zhiqing YANG, Liang ZHANG, Xiangyang ZHANG, Zhenjuan SHI, Di SU, Hongying LUO, Dejin FU
  • Publication number: 20180099930
    Abstract: Disclosed is a new method for preparing an azetidinone compound represented by formula (I). The carboxylic ketoester represented by formula (II) serves as the raw material and is subjected to Grignard addition, stereoselective dehydration, ester group reduction, hydroxyl group protection, addition with imine after condensation with a chiral auxiliary, cyclization and deprotection to obtain the compound represented by formula (I). The present invention has advantages of easily available raw material, a few synthetic steps, simple operation, high yield, good stereoselectivity and low cost, and can be used for industrial production.
    Type: Application
    Filed: December 8, 2017
    Publication date: April 12, 2018
    Applicant: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Hua Bai, Xuyang Zhao, Yuncai Zhang, Xufei Li, Yong Zhang, Dezhou Xu, Li Zhang, Xiaojie Xu, Qifeng Zhu, Xiaoming Wang, Zhiqing Yang, Zehua Zhong, Jian Zhang
  • Patent number: 9926268
    Abstract: Disclosed is a new method for preparing an azetidinone compound represented by formula (I). The carboxylic ketoester represented by formula (II) serves as the raw material and is subjected to Grignard addition, stereoselective dehydration, ester group reduction, hydroxyl group protection, addition with imine after condensation with a chiral auxiliary, cyclization and deprotection to obtain the compound represented by formula (I). The present invention has advantages of easily available raw material, a few synthetic steps, simple operation, high yield, good stereoselectivity and low cost, and can be used for industrial production.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: March 27, 2018
    Assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.
    Inventors: Hua Bai, Xuyang Zhao, Yuncai Zhang, Xufei Li, Yong Zhang, Dezhou Xu, Li Zhang, Xiaojie Xu, Qifeng Zhu, Xiaoming Wang, Zhiqing Yang, Zehua Zhong, Jian Zhang